Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Invasive Cancer or Ductal Carcinoma in Situ
and you are
between 40 and 59
years old
The phase for this study is not defined.
Show me locations

The purpose

Mammography screening has limited performance in young women or women with dense breasts although it is the only proven method for breast cancer screening that reduces the mortality. The investigators propose a multicenter trial of breast cancer screening to assess the effectiveness of supplemental ultrasonography for Korean women aged 40-59 years.

Provided treatments

  • Device: Ultrasonography
  • Device: Digital mammography
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02909426. The sponsor of the trial is Soonchunhyang University Hospital and it is looking for 20000 volunteers for the current phase.
Official trial title:
Effectiveness of Breast Cancer Screening in Women Aged 40-59: Digital Mammography With Supplemental Breast Ultrasonography Versus Digital Mammography Only